Abbvie Inc



+23.6% last 12 months

Market Cap

$235 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$97.28 - $137.98

The lowest and highst price in the last 52 weeks.

Price-Earnings Ratio


The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$5.23 (3.93%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Market Cap $235 Billion
Enterprise Value $304 Billion
Dividend Yield $5.23 (3.93%)
1 Year Return +27.6%
52-Week High $137.98
52-Week Low $97.28
Beta 0.57
Outstanding Shares 1.77 Billion
Avg 30 Day Volume 6.95 Million


P/E Ratio 31.51
PEG 83.26
Earnings per Share $4.19
Price to Sales Ratio 4.26
Price to Book Ratio 18.85
Revenue to Enterprise Value 5.5
EBIT to Enterprise Value 16.97
Total Debt to Enterprise Value 0.27
Debt to Equity 5.96


Revenue $55.2 Billion
Gross Profit $37.4 Billion
EBIT $17.9 Billion
Net Income $7.46 Billion
Profit Margin 13.52%
Quarterly Earnings Growth (YoY) +37.8%
Return on Equity 55.06%
Return on Assets 5.01%
Return on Invested Capital 14.87%

Insider trades

No purchases

4,184 shares sold (1 transactions)

No purchases

5,057 shares sold (1 transactions)

No purchases

114,857 shares sold (5 transactions)

No purchases

No sells

Q2 2021 Q3 2021 Q4 2021 Q1 2022

About Abbvie Inc

CEO: Richard Gonzalez

Industry: Pharmaceutical Preparation Manufacturing

Similar stocks

Pfizer Inc.
Pfizer Inc.
Lilly(Eli) & Co
Lilly(Eli) & Co
Gilead Sciences, Inc.
Gilead Sciences, Inc.
Biogen Inc
Biogen Inc
Glaxosmithkline plc - ADR
Glaxosmithkline plc - ADR
Astrazeneca plc - ADR
Astrazeneca plc - ADR
Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc.